Cargando…
Potential biomarkers and targets in reversibility of pulmonary arterial hypertension secondary to congenital heart disease: an explorative study
Whether pulmonary arterial hypertension (PAH) is reversible in congenital heart disease (CHD) is important for the operability of CHD. However, little is known about that. Our research was aimed at exploring novel biomarkers and targets in the reversibility of CHD-PAH. CHD-PAH patients diagnosed wit...
Autores principales: | Huang, Li, Li, Li, Hu, Enci, Chen, Guo, Meng, Xianmin, Xiong, Changming, He, Jianguo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5865461/ https://www.ncbi.nlm.nih.gov/pubmed/29480151 http://dx.doi.org/10.1177/2045893218755987 |
Ejemplares similares
-
Transgelin as a potential target in the reversibility of pulmonary arterial hypertension secondary to congenital heart disease
por: Huang, Li, et al.
Publicado: (2018) -
The expression of survivin in irreversible pulmonary arterial
hypertension rats and its value in evaluating the reversibility of pulmonary
arterial hypertension secondary to congenital heart disease
por: Li, Gang, et al.
Publicado: (2019) -
Effect of iloprost on biomarkers in patients with congenital heart disease‐pulmonary arterial hypertension
por: Li, Xiao‐ye, et al.
Publicado: (2017) -
Incorporation of noninvasive assessments in risk prediction for pulmonary arterial hypertension
por: Quan, Ruilin, et al.
Publicado: (2022) -
Better Outcomes in Pulmonary Arterial Hypertension After Repair of Congenital Heart Disease, Compared With Idiopathic Pulmonary Arterial Hypertension
por: Xu, Zhuoyuan, et al.
Publicado: (2021)